CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Go Home tablet with linked GoSpiro and 3230 Pulse Oximeterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04369885
NCT04369885N/ACompleted
CompareCT.gov

Assessing Adherence to Home Telemedicine in Individuals With COPD

University of North Carolina, Chapel Hill·interventional·Posted Apr 30, 2020·Updated Nov 3, 2021

In Brief

A clinical study evaluating Go Home tablet with linked GoSpiro and 3230 Pulse Oximeter for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 12 participants across 1 site.

Detailed Summary

This is a single-site feasibility pilot study to determine if patients with COPD with an increased risk of exacerbation will use an in-home COPD telemonitoring system for three months that collects lung measures, pulse oximetry, and medication compliance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesUnited States
CollaboratorsMidmark Corporation, Monitored Therapeutics, Inc

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 30, 2020
Enrollment StartJul 1, 2020
Primary CompletionMay 24, 2021
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 6.2 years ago

Interventions

Go Home tablet with linked GoSpiro and 3230 Pulse Oximeterdevice

All participants will receive the intervention consisting of a home telemedicine tablet platform (GoHome) that will collect multiple spirometry tests each week (including both forced and slow spirometry measurements), pulse oximetry, and QoL Questionnaire responses. The platform will remind patients to take their medications remind patients to perform measurements, send patients helpful information, and execute a UNC clinic established COPD Action Plan.The backend of the platform is a remote server (Monitored Therapeutics CarePortal) that collects the data, send out alerts to the Principal Investigator and can track and trend the data for them.